Impaired Vγ2Vδ2+T lymphocytes responses during Mycobacterium tuberculosis infection in human immunodeficiency virus infected individuals
10.3760/cma.j.issn.1000-6680.2009.07.007
- VernacularTitle:人类免疫缺陷病毒合并结核感染患者外周血Vγ2Vδ2+T淋巴细胞的数量与功能变化
- Author:
Shenglei YU
;
Lingyun SHAO
;
Jialin JIN
;
Shu ZHANG
;
Wenhong ZHANG
;
Shu CHEN
- Publication Type:Journal Article
- Keywords:
Vγ2Vδ2-positive T-lymphocytes;
Tuberculosis;
HIV infections
- From:
Chinese Journal of Infectious Diseases
2009;27(7):413-417
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the number and function of peripheral Vγ2Vδ2+T lymphocytes during Mycobacterium tuberculosis(MTB)infection in human immunodeficiency virus (HIV)infected individuals.Methods Seventy-six HIV/acquired immune deficiency syndrome(AIDS) patients co-infected with MTB were divided into active tuberculosis(TB)group(HIV+TB)and latent TB group(HIV+LTB).T cell subsets of peripheral blood lymphocytes were analysed by flow cytometry.Stimulated by protein purified derivative(PPD)and hydroxymethylbutenyl diphosphate (HMBPP),specific interferon(IFN)-γ producing T cells were detected using enzyme-linked immunospot(ELISPOT)and intracellular cytokine staining(ICS).Data were analyzed by t test.Results The absolute number of CD3'T cells and DroDortion of V72VB2'T cells in CD3+T cells in HIV+TB group were both significantly lower than those in HIV+LTB group(t=-3.67,P<0.01;t=-2.06,P<0.05).PPD-specific IFN-y-producing T cells and percentage of PPD-specific CD4+Tcells in CD3+T cells in HIV+LTB group were both similar with those in HIV+TB group.While HMBPP-specific IFN-γ-producing T cells and percentage of HMBPP-specific Vγ2Vδ2+T cells in CD3+Tcells in HIV+LTB group were both higher than those in HIV+TB group(t=2.71 and t=3.003,respectively;both P<0.0 1).Conclusion The number and function of Vγ2Vδ2+T cells were impaired in HIV/AIDS patients coinfected with active MTB infection,which indicates that Vγ2Vδ2+T cells may be the key immune cells against MTB in individuals with impaired CD4+T cells.